Get the Daily Brief
Latest Biotech News
Amgen’s PCSK9 Drug Sets Heart Risk Prevention Benchmark
Amgen announced compelling data from a 12,000-patient trial demonstrating that its cholesterol-lowering drug Repatha significantly reduces the risk of heart disease death, heart attacks, and...
FDA Approvals Advance Lung Cancer and Abortion Pill Therapies
The U.S. FDA approved Jazz Pharmaceuticals and Roche’s combination as a first-line maintenance therapy for extensive-stage small-cell lung cancer, based on the phase III Imforte study...
Rocket Pharmaceuticals Withdraws Gene Therapy Application for Fanconi Anemia
Following strategic reprioritization, Rocket Pharmaceuticals voluntarily withdrew its FDA biologics license application for RP-L102, a gene therapy targeting Fanconi anemia. The company cited...
Nanyang Biologics Pursues Nasdaq Listing via $1.5 Billion SPAC Deal
Singapore-based Nanyang Biologics has entered a $1.5 billion business combination agreement with Nasdaq-listed special purpose acquisition company RF Acquisition Corp II. The biotech leverages AI...
AI-Driven Protein Design Surpasses Nature in Genome Editing Innovations
Researchers from Integra Therapeutics, in collaboration with Pompeu Fabra University and the Center for Genomic Regulation, have experimentally validated synthetic proteins engineered via...
Breakthrough in Kidney Transplantation: Enzyme Technology Enables Universal Donor Organs
Scientists at the University of British Columbia have successfully conducted the first human transplant of a kidney enzymatically converted from blood type A to universal type O. The enzyme...
Immunotherapy and Cancer Precision Medicine See Advances Through Biomarker and Antibody Development
Several biotech firms and research institutions reported breakthroughs in immuno-oncology. Cartography Biosciences secured a $67 million Series B to progress T-cell engaging bispecific antibodies...
Psilocybin Shows Promise for Dual Relief of Chronic Pain and Depression
Groundbreaking research at the University of Pennsylvania demonstrates that a single dose of psilocybin, the psychoactive compound in psychedelic mushrooms, rapidly and sustainably alleviates pain...
Biopharma Financing Trends Indicate Strategic Shifts Amid Market Uncertainty
Recent analyses reveal that biopharma financings totaled $47.1 billion from January through September 2025, down sharply from $86.7 billion in 2024 during the same period, predominantly due to...
NIH and Federal Science Community Face Impact from Government Shutdown
The ongoing federal government shutdown has led to significant disruptions across U.S. science agencies, notably halting new grant awards from NIH and NSF and suspending various research programs....
FDA Approves Jazz-Roche Lung Cancer Combination Ahead of Schedule
The U.S. Food and Drug Administration has granted early approval for Jazz Pharmaceuticals' and Roche's combination therapy of Zepzelca (lurbinectedin) with Tecentriq (atezolizumab), including...
Rocket Pharmaceuticals Withdraws FDA Application for Fanconi Anemia Gene Therapy
Rocket Pharmaceuticals has voluntarily withdrawn its biologics license application to the FDA for RP-L102, a gene therapy candidate targeting Fanconi anemia, a rare blood disorder. This decision...
Nanyang Biologics Pursues $1.5 Billion Nasdaq Listing via SPAC
Singapore-based Nanyang Biologics (NYB) has entered a business combination agreement valued at $1.5 billion with Nasdaq-listed special purpose acquisition company RF Acquisition Corp II. NYB...
Biopharma Financing Slows in 2025 with Notable September Uptick
Global biopharma fundraising has experienced a marked slow-down in 2025, with total capital raised through September reaching $47.1 billion, substantially lower than the $86.7 billion raised...
Breakthrough Study Unveils Largest Genetic Map of Human Metabolism
Researchers have constructed the largest genetic map linking human genetics and metabolism by analyzing data from approximately 450,000 individuals via the UK Biobank. Employing nuclear magnetic...
Amgen’s Repatha Shows Heart Risk Reduction in Large-Scale Primary Prevention Trial
Amgen announced new data from a 12,000-patient trial showing that its cholesterol-lowering drug Repatha (a PCSK9 inhibitor) effectively reduces the risk of death from cardiovascular disease, heart...
Advances in Psilocybin Research Show Potential to Treat Chronic Pain and Depression
A team at the University of Pennsylvania uncovered how a single dose of psilocybin, the active compound in psychedelic mushrooms, rapidly and durably alleviates both chronic pain and...
University of British Columbia Achieves First Enzyme-Enabled Universal Donor Organ Transplant
Researchers at the University of British Columbia demonstrated the first successful human transplant of a kidney converted from blood type A to universal type O using specialized enzyme...
AI Protein Design Surpasses Natural Counterparts in Genome Editing Efficiency
Researchers at Integra Therapeutics, in collaboration with Pompeu Fabra University and the Center for Genomic Regulation, have developed synthetic proteins designed through generative AI that...
Asabys Partners and Aliath Bioventures Merge to Form $468 Million Life Sciences Platform
Spanish investment firms Asabys Partners and Aliath Bioventures have merged in a strategic consolidation, elevating Asabys' assets under management from $351 million to over $468 million. This...